(Q35175438)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12855255%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Molecular prognostication in bladder cancer--a current perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12855255%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12855255%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Siamak Daneshmand

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12855255%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

M L Quek

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12855255%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J P Stein

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12855255%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12855255%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12855255%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12855255%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12855255%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

1501-1510

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12855255%20AND%20SRC:MED&resulttype=core&format=json

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Expression of ras p21 oncogene product on human bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Point mutations of c-ras genes in human bladder cancer and kidney cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Evaluation of c-ras oncogene product (p21) in superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Detection of the c-myc gene product in urinary bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Expression and characterization of the human c-myc DNA-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Initiation-development modelling of allelic losses on chromosome 9 in multifocal bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Altered Expression of Retinoblastoma Protein and Known Prognostic Variables in Locally Advanced Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

The genetics of transitional cell carcinoma: progress and potential clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Growth arrest and suppression of tumorigenicity of bladder-carcinoma cell lines induced by the P16/CDKN2 (p16INK4A, MTS1) gene and other loci on human chromosome 9

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

p53 mutations in human bladder cancer: genotypic versus phenotypic patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

1 reference

7 January 2021

A long twentieth century of the cell cycle and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

1 reference

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer. Finbladder Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Cyclin E and survival in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Cyclin E and prognosis in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Effects of physiologic pacing versus ventricular pacing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

1 reference

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

The pathophysiology of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Quantification of angiongenesis as an independent predictor of prognosis in invasive bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

URINARY VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS CORRELATION WITH BLADDER CANCER RECURRENCE RATES

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Expression of scatter factor in human bladder carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

CD44: structure, function, and association with the malignant process.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Expression of CD44 splice variants in human transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Specific association between the human DNA repair proteins XPA and ERCC1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Purification and characterization of the XPF-ERCC1 complex of human DNA repair excision nuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Assembly, subunit composition, and footprint of human DNA repair excision nuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Role of ERCC1 in removal of long non-homologous tails during targeted homologous recombination

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

DNA repair and cisplatin resistance in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Action of DNA repair endonuclease ERCC1/XPF in living cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

ERCC1/ERCC4 5'-endonuclease activity as a determinant of hypoxic cell radiosensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Options available--from start to finish--for obtaining expression data by microarray.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

The application of tissue microarrays to cancer research

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021

Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900300-9

7 January 2021